Provided by Tiger Trade Technology Pte. Ltd.

Kiora Pharmaceuticals

2.54
+0.01000.40%
Post-market: 2.550.0100+0.39%16:00 EDT
Volume:4K
Turnover:11.40K
Market Cap:11.26M
PE:-1.05
High:2.57
Open:2.52
Low:2.52
Close:2.53
52wk High:2.91
52wk Low:1.76
Shares:4.43M
Float Shares:4.29M
Volume Ratio:0.29
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4100
EPS(LYR):-2.6400
ROE:-56.36%
ROA:-21.92%
PB:0.67
PE(LYR):-0.96

Loading ...

Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 29, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 29, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 27, 2024

Correspondence

Form CORRESP - Correspondence
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Major Issues Report

Form 8-K - Current report